the bmj says drug company novartis ( pictured ) has consistently tried to ‘ undermine and divert attention’ from trials to prove avastin works – even turning to the royal national institute of blind people for help . bmj editor in chief , dr fiona godlee , said the new evidence ‘ raises questions about the legal and regulatory positions that have skewed clinical practice , fuelled nhs drug costs , and left doctors confused about what they can and can’t prescribe’ . the rnib told the bmj that last year only 0.3 per cent of its total income was from drug companies .